University of Alabama at Birmingham, Birmingham, AL.
Eye Contact Lens. 2021 Feb 1;47(2):74-80. doi: 10.1097/ICL.0000000000000690.
Many contact lens (CL) users permanently discontinue wear because of ocular dryness and discomfort. This study aimed to determine whether refitting symptomatic soft CL wearers in to orthokeratology could improve ocular symptoms and signs.
This was a prospective, 3-month, open-label study of symptomatic (Contact Lens Dry Eye Questionnaire [CLDEQ-8] ≥12) soft CL wearers who were between the ages of 18 and 45 years. All subjects were refit into orthokeratology CLs (Emerald, Euclid Systems). The following tests were completed: CL history, Standardized Patient Evaluation of Eye Dryness (SPEED) questionnaire, CLDEQ-8, CLDEQ-4, logarithm of the minimum angle of resolution visual acuity, pupil size, refractive error, slit-lamp biomicroscopy, noninvasive tear break-up time, tear meniscus height, phenol red thread, conjunctival staining, corneal aesthesiometry, and corneal topography.
Twenty-nine of 40 qualifying subjects (age=24.43±4.62 years) completed the study. No significant differences were detected between completed and noncomplete subjects. Completed subjects had significantly better CLDEQ-8, CLDEQ-4, and SPEED scores at 3 months compared with baseline. Completed subjects had significantly better conjunctival staining scores and flatter keratometry values at 1 month compared with baseline.
Although not all symptomatic soft CL wearers were able to be refit into orthokeratology, subjects who were wearing orthokeratology at 3 months had a significant and clinically meaningful improvement in ocular symptoms. Additional work is needed to determine the mechanism leading to improved comfort because few clinical signs were changed after switching to orthokeratology.
许多隐形眼镜(CL)使用者因眼部干燥和不适而永久停止佩戴。本研究旨在确定对有症状的软性 CL 佩戴者进行角膜塑形术重新配镜是否可以改善眼部症状和体征。
这是一项前瞻性、3 个月、开放标签的研究,纳入了年龄在 18 至 45 岁之间、有症状(接触镜干眼问卷 [CLDEQ-8]≥12)的软性 CL 佩戴者。所有患者均重新配镜为角膜塑形镜(Emerald、Euclid Systems)。完成以下测试:隐形眼镜史、标准化患者眼干评估量表(SPEED)问卷、CLDEQ-8、CLDEQ-4、最小分辨角对数视力、瞳孔大小、屈光不正、裂隙灯生物显微镜、非侵入性泪膜破裂时间、泪膜高度、苯酚红线、结膜染色、角膜知觉测量和角膜地形图。
在符合条件的 40 名受试者中,有 29 名(年龄=24.43±4.62 岁)完成了研究。完成和未完成研究的受试者之间没有显著差异。与基线相比,完成研究的受试者在 3 个月时 CLDEQ-8、CLDEQ-4 和 SPEED 评分显著改善。与基线相比,完成研究的受试者在 1 个月时结膜染色评分和角膜曲率值显著更平坦。
尽管并非所有有症状的软性 CL 佩戴者都能重新配镜为角膜塑形镜,但在 3 个月时佩戴角膜塑形镜的患者眼部症状有显著且具有临床意义的改善。需要进一步研究确定导致舒适度改善的机制,因为在切换为角膜塑形镜后很少有临床体征发生改变。